Just In
- 2 hrs ago Golden Rules To Follow For Happy Marriage For A Long Lasting Relationship
- 2 hrs ago Gajalakshmi Rajyog In Aries 2024: Lucky Zodiac Signs Who Will Get Financial Benefits
- 6 hrs ago Met Gala 2024: Date, Theme, Venue, Guest List, All You Need To Know About The Fashion Event
- 12 hrs ago Summer Fashion: Your Bollywood Style White Outfits Guide To Keep It Cool And Chic
Don't Miss
- Sports Who Won Yesterday's IPL Match 34? LSG vs CSK, IPL 2024 on April 19: KL Rahul Stellar Batting Show Decimate Chennai Bowling
- Finance Rs 17/Share Dividend: Record Date On April 26; Buy The ICICI Group Stock To Be Eligible?
- Movies Chief Detective 1958 Episode 2 OTT Release Date, Time, Platform: When & Where To Watch? What To Expect? DEETS
- News Chinese President Xi Jinping Orders Biggest Military Reorganisation Since 2015
- Education Exam Pressure Does Not Exist; Studying Punctually is Crucial; Says Aditi, the PSEB 2024 Topper
- Automobiles Suzuki Swift Hatchback Scores 4 Star Safety Rating At JNCAP – ADAS, New Engine & More
- Technology Dell Introduces AI-Powered Laptops and Mobile Workstations for Enterprises in India
- Travel Journey From Delhi To Ooty: Top Transport Options And Attractions
St. John's Wort May Not Treat ADHD In Kids
Researchers at Bastyr University, Kenmore, Washington, have found that kids and teens with attention-deficit/hyperactivity disorder (ADHD) who were treated with the herb St. John's wort did not have any greater improvement in ADHD symptoms as compared to those who received a placebo.
For the study, Wendy Weber, N.D., Ph.D., M.P.H., of Bastyr University, Kenmore, Wash., and colleagues conducted a clinical trial of St. John's wort (Hypericum perforatum) on 54 kids and teens with ADHD, age 6 to 17 years, to determine whether this agent was effective in lessening the severity of ADHD symptoms.
During the study, 27 participants were randomly assigned to receive 300 mg of H perforatum standardized to 0.3 percent hypericin (a compound derived from H perforatum) and 27 participants received a matched placebo, three times daily for eight weeks.
The study showed that there were no significant differences between the two groups in the change in ADHD rating scale scores from the start of the trial to week 8 and in change in scores rating inattentiveness and hyperactivity.
Researchers found that there was also no difference in the proportion of participants who were rated as much or very much improved regarding ADHD symptoms on another measurement scale.
No statistically significant difference was found between the two groups in the proportion of participants who experienced 1 or more rash, nausea/vomiting, headache, or sunburn during the trial.
"To our knowledge, this is the first placebo-controlled trial of H perforatum in children and adolescents. The results of this study suggest that administration of H perforatum has no additional benefit beyond that of placebo for treating symptoms of child and adolescent ADHD," the authors said.
The study is published in the June 11 issue of JAMA.
- pregnancy parentingWhat Are The 5 C's Of ADHD Parenting? How Can It Help Improve Parent-Child Bond?
- kidsUnderstanding Attention Deficit Hyperactivity Disorder: How To Support Children With ADHD
- kidsADHD: A Guide To Packing School Backpacks For Children With ADHD
- kidsOppositional Defiant Disorder (ODD) In Children: Causes, Symptoms, Complications And Treatments
- disorders cureComputer/Internet Addiction: Is It A Habit Or Addiction? Types, Causes, Diagnosis And Treatments
- disorders cureGuide To Preparing Your Child With ADHD For School
- kidsADHD In Children: Signs, Symptoms and Treatment
- disorders cure8 Medical Reasons Why You Feel Irritated All The Time!
- newsThe Vicious Cycle of ADHD and Sleep Deprivation: New Research
- wellnessWorkaholics More likely To Suffer From ADHD, OCD and Depression
- wellnessWomen With ADHD More Likely To Have Suicidal Thoughts-Finds Study
- kidsWays To Deal With A Child's ADHD Behaviour